AMGN AMGEN Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: AMGN

Price (delayed)

$465.67

Market cap

$251.89B

P/E Ratio

26.79

Dividend/share

$9.94

EPS

$17.38

Enterprise value

$292.7B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 95

Amgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world's toughest diseases. Harnessing the best of biology and technology, Amgen reaches millions of patients with its ...

Highlights
AMGEN's equity has increased by 49% YoY and by 23% from the previous quarter
The net income has grown by 34% YoY and by 7% from the previous quarter
The P/E is 14% above the last 4 quarters average of 23.4 and 4.2% above the 5-year quarterly average of 25.7
Sector: Healthcare
Industry: Drug Manufacturers - General
Website: http://www.amgen.com
Peers: BMY PFE GILD ABBV

Key stats

What are the main financial stats of AMGN

AMGN stock price

How has the AMGEN stock price performed over time
Intraday
-0.3%
1 week
1.14%
1 month
12.8%
1 year
38.59%
YTD
42.27%
QTD
10.48%

Financial performance

How have AMGEN's revenue and profit performed over time
Revenue
$38.9B
Gross profit
$27.58B
Operating income
$12.61B
Net income
$9.39B
Gross margin
70.9%
Net margin
24.1%
AMGN's operating income is up by 45% year-on-year and by 10% since the previous quarter
The net income has grown by 34% YoY and by 7% from the previous quarter
The company's operating margin rose by 34% YoY and by 8% QoQ
The net margin rose by 24% year-on-year and by 4.8% since the previous quarter

Price vs fundamentals

How does AMGN's price correlate with its fundamentals

Growth

What is AMGEN's growth rate over time

Valuation

What is AMGEN stock price valuation
AMGN P/E details
P/E
26.79
P/B
17.54
P/S
6.48
EV/EBIT
21.38
EV/EBITDA
16.11
EV/Sales
7.52
AMGN's EPS is up by 33% year-on-year and by 7% since the previous quarter
The P/E is 14% above the last 4 quarters average of 23.4 and 4.2% above the 5-year quarterly average of 25.7
AMGEN's equity has increased by 49% YoY and by 23% from the previous quarter
The stock's price to book (P/B) is 43% less than its 5-year quarterly average of 30.9 and 4.7% less than its last 4 quarters average of 18.4
The P/S is 30% more than the 5-year quarterly average of 5.0 and 25% more than the last 4 quarters average of 5.2
The revenue has grown by 8% year-on-year and by 2.1% since the previous quarter

Efficiency

How efficient is AMGEN business performance
AMGN's return on assets is up by 28% year-on-year and by 5% since the previous quarter
The ROIC has grown by 20% YoY and by 3.9% from the previous quarter
AMGN's return on sales is up by 14% year-on-year and by 3.5% since the previous quarter
The ROE has contracted by 11% YoY and by 4.1% from the previous quarter

Dividends

What is AMGN's dividend history
Dividend details
DPS
$9.94
Dividend yield
2.13%
Payout ratio
57.2%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did AMGEN financials performed over time
AMGEN's total assets is 18% more than its total liabilities
AMGN's quick ratio is up by 23% year-on-year and by 6% since the previous quarter
AMGEN's current ratio has increased by 16% YoY and by 8% from the previous quarter
AMGEN's equity has increased by 49% YoY and by 23% from the previous quarter
AMGN's debt to equity is down by 34% YoY and by 23% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.